Immune Profiles and Circulating Tumor Cell Status Following Prostate Cryotherapy

NCT01454037 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 160

Last updated 2012-11-14

No results posted yet for this study

Summary

The change of immune profiles and existence of circulating tumor cells following prostate cryotherapy may be correlated with the clinical outcome.

Conditions

  • Prostate Cancer
  • Immune Profile
  • Circulating Cancer Cells
  • Clinical Corelation

Interventions

PROCEDURE

Prostate cryotherapy

cryoablate the prostate

PROCEDURE

Radical prostatectomy

Remove prostate

PROCEDURE

Radiation

Radiate prostate

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Yeong-Shiau Pu, PhD · National Taiwan University Hospital

Eligibility

Min Age
20 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2013-10-31
Completion
2015-10-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01454037 on ClinicalTrials.gov